Our Take
Provider-led plans exist but underperform in a market segment where vertical integration should work; McKinsey names the gap without naming the fix.
Why it matters
Health systems and insurance executives evaluate vertical integration as a defensive and revenue strategy. A quantified market opportunity signals whether provider-led plans deserve capital allocation or remain a distraction from core operations.
Do this week
Health system CFO: audit your current commercial plan enrollment and margin contribution against McKinsey's $20B addressable pool this quarter so you can benchmark your competitive position before 2025 budget lock.
The $20 billion opportunity gap
Provider-led health plans operate in the commercial group insurance market but capture a smaller share than their scale and network advantages would suggest. McKinsey estimates this underrepresentation leaves $20 billion in potential revenue and $700 million in operating margin unrealized (per McKinsey Insights).
The gap exists despite structural advantages that favor provider ownership: integrated care delivery, lower claims volatility from managed patient populations, and existing relationships with employers. Yet provider-led plans have not achieved the market penetration seen by traditional commercial insurers or regional competitors.
Vertical integration without execution
The discrepancy reveals a recurring pattern in healthcare: capability without conversion. Health systems and hospital networks possess the clinical assets, patient data, and scale needed to operate insurance products profitably. Operating margin of $700 million annualized across an addressable segment signals that profitability is not the structural problem.
The barrier appears organizational rather than financial. Provider-led plans require distinct expertise in underwriting, regulatory compliance, sales operations, and actuarial modeling that differ from clinical delivery. Execution risk and resource allocation trade-offs likely explain why many health systems have deprioritized or underinvested in insurance products relative to hospital operations.
This matters to health system boards and CFOs evaluating M&A targets, vertical integration strategy, and capital deployment. A $20 billion addressable market that remains partly uncontested is material enough to justify strategic review, but only if the operating constraints that have blocked prior entrants have been solved.
What to audit
Health system finance teams should review three dimensions. First, current provider-led plan enrollment and margin contribution as a percentage of total health system revenue, compared against the national competitive baseline. Second, the staffing and functional capability gaps between your insurance operation and competitors that have grown share. Third, whether underinvestment is a choice (strategic de-prioritization) or a constraint (capital shortage, executive bandwidth, regulatory friction).
McKinsey's framing suggests the opportunity is real but execution capability varies. The question for each health system is whether closing a gap in your market segment requires new investment or signals that provider-led insurance is a lower-priority use of capital than alternatives.